ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2129

Fracture Risk Assessment Tool (FRAX®) Scores Predict Mortality in Community-Dwelling Elderlies

Thiago Quadrante Freitas1, Leonardo Olalla2, Luana Machado3, Camille Figueiredo3, Liliam Takayama4, Valeria Caparbo3, Ricardo Oliveira5, Diogo Domiciano1 and Rosa M R Pereira3, 1Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Quito, Ecuador, 3Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., São Paulo, SP, Brazil, 4Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 5RDO DIAGNÓSTICOS MÉDICOS, São Paulo, SP, Brazil

Meeting: ACR Convergence 2024

Keywords: Bone density, Cohort Study, Fracture, Mortality, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The World Health Organization Fracture Risk Assessment Tool (FRAX®) was developed to estimate the 10-year absolute probability of osteoporotic fractures among the general population. In Brazil, the National Osteoporosis Guideline Group (NOGG) methodology is used to categorize absolute fracture risk obtained from FRAX into low, intermediate, and high risk. Although osteoporotic fracture and low bone mass are risk factors for death, the association between FRAX® and mortality is unknown. Therefore, this population-based prospective cohort study was conducted to evaluate the predictive ability of the FRAX® for all-cause and cardiovascular deaths in Brazilian community-dwelling elderlies.

Methods: A total of 835 older adults (513 women; 322 men), aged over 65 years, from a Brazilian population-based prospective cohort, were included in this analysis. FRAX probability and NOGG risk stratification were calculated for all subjects at baseline. The Cox proportional hazards model was employed to calculate hazard ratios and 95% confidence intervals. The backward likelihood ratio with stepwise selection method was utilized to identify the variables in the final models (entry: p< 0.05; removal: p >0.10) for all-cause and cardiovascular (CV) mortality. Kaplan-Meier curves for survival were generated, and comparisons were conducted using log-rank tests.

Results: Throughout the mean follow-up period of 4.06±1.07 years, 129 (15.4%) deaths occurred, comprising 66 women and 63 men, with 56 (43.4%) attributed to cardiovascular (CV) causes. The mean FRAX® scores for major osteoporotic fracture were 10.0±8.6% and 7.4±5.0% in the deceased and surviving groups, respectively. Univariate analyses revealed that the deceased group exhibited lower hip bone mineral density (BMD), along with higher FRAX values and risk classifications (Fig. 1). Following adjustments for other significant mortality risk factors within this population (including age, sex, recurrent falls, physical activity score, diabetes mellitus, prior cardiovascular events, hip BMD, and intact parathyroid hormone levels), multivariate Cox regression analyses identified the high-risk category for major osteoporotic fracture (HR 2.06, 95% CI 1.07-3.97, P=0.03) and hip fracture (HR 2.11, 95% CI 1.14-3.90, P=0.017) as independent predictors of all-cause mortality (Fig. 2 and Fig. 3). Due to the limited number of CV deaths, the multivariate analysis for CV mortality indicated only a trend for high-risk categories for major osteoporotic fracture (HR 2.21, 95% CI 0.94-5.22, P=0.07) and hip fracture (HR 2.38, 95% CI 0.92-6.18), as well as FRAX absolute probability for hip fracture (HR 1.04, 95% CI 0.998-1.09, p=0.063, per each 1%-increase) (Fig. 2).

Conclusion: Among the elderly Brazilian population residing in the community, the FRAX® tool appears to be useful in predicting mortality risk.

Supporting image 1

Figure 1. Differences between the deceased and alive groups regarding FRAX scores (upper left) and Hip BMD (upper right), shown as bar graphs (continuous variables), and differences between the deceased and alive groups regarding the proportions (discrete variables) of low, intermediate and high risk of fractures (bottom).

Supporting image 2

Figure 2. Forest plots for the hazard ratios and respective 95% confidence intervals, for each FRAX score (major fractures with and without BMD, and hip fractures with and without BMD) and risk classification (high, intermediate and low, with and without BMD), regarding all-cause mortality (upper plots), and cardiovascular mortality (bottom plots).

Supporting image 3

Figure 3. Kaplan-Meier survival curves according to the risk classifications for hip fractures (left) and major osteoporotic fractures (right), showing longer survival for those with low risk of fractures, and shorter survival for those with high risk.


Disclosures: T. Freitas: None; L. Olalla: None; L. Machado: None; C. Figueiredo: None; L. Takayama: None; V. Caparbo: None; R. Oliveira: None; D. Domiciano: None; R. Pereira: None.

To cite this abstract in AMA style:

Freitas T, Olalla L, Machado L, Figueiredo C, Takayama L, Caparbo V, Oliveira R, Domiciano D, Pereira R. Fracture Risk Assessment Tool (FRAX®) Scores Predict Mortality in Community-Dwelling Elderlies [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/fracture-risk-assessment-tool-frax-scores-predict-mortality-in-community-dwelling-elderlies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fracture-risk-assessment-tool-frax-scores-predict-mortality-in-community-dwelling-elderlies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology